Published • loading... • Updated
The Nano Liposome Nasal Spray Developed at BANU Will Be Tested on 126 Volunteers.
Summary by Haberler
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
A clinical trial will be conducted for a nano-liposome-based nasal spray developed domestically within the BANU Faculty of Medicine. The formulation, which reached the clinical stage after 9 years of R&D, will be examined using a double-blind method on 126 volunteers with viral upper respiratory tract infections.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
